- Home
- IMCC vs CRIS Comparison
IMCC vs CRIS Comparison
Compare IMCC & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMCC | CRIS |
|---|---|---|
| Founded | 1980 | 2000 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0M | 976.1K |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | IMCC | CRIS |
|---|---|---|
| Price | $0.68 | $0.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $42.67 |
| AVG Volume (30 Days) | 71.7K | ★ 582.9K |
| Earning Date | 11-16-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.57 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,898,000.00 |
| Revenue This Year | $60.66 | N/A |
| Revenue Next Year | $6.68 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.09 | $0.33 |
| 52 Week High | $8.65 | $2,981.00 |
Technical Indicators
Market Signals| Indicator | IMCC | CRIS |
|---|---|---|
| Relative Strength Index (RSI) | 33.61 | 29.19 |
| Support Level | $0.60 | $0.33 |
| Resistance Level | $1.05 | $5.50 |
| Average True Range (ATR) | 0.12 | 0.09 |
| MACD | -0.04 | 0.45 |
| Stochastic Oscillator | 2.26 | 97.66 |
Price Performance
Historical ComparisonAbout IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.